10x Genomics, Inc. Profile Avatar - Palmy Investing

10x Genomics, Inc.

10x Genomics, Inc., a life science technology company, develops and sells instruments, consumables, and software for analyzing biological systems in North America, Europe, the Middle East, Africa, China, and the Asia Pacific. The company provides chromiu…
Medical - Healthcare Information Services
US, Pleasanton [HQ]
TXG/Financial Reporting

Income Statements

7 Sheets · Starting from 2023
In Million USD. Margins, Growth Rates In %
Metric 2017 2018 2019 2020 2021 2022 2023
Revenue
71.00 146.00 245.00 298.00 490.00 516.00 618.00
EPS
-1.62 -8.40 -0.80 -5.37 -0.53 -1.46 -2.18
Profit
60.00 117.00 184.00 240.00 416.00 396.00 409.00
Pre Tax
-18.00 -112.00 -31.00 -534.00 -53.00 -161.00 -248.00
ETR
- - - - -0.70 -1.54 -8.39 -2.49 -2.55
Net
-18.00 -112.00 -31.00 -542.00 -58.00 -166.00 -255.00
EBITDA
-13.00 -13.00 -26.00 -82.00 -53.00 -161.00 -158.00
Operating Income
-18.00 -110.00 -29.00 -85.00 -52.00 -167.00 -201.00
Interest Income
- - 1.00 2.00 1.00 - - 6.00 16.00
Loss
-89.00 -164.00 -274.00 -384.00 -543.00 -684.00 -820.00
Cost of Revenue
-10.00 -28.00 -61.00 -58.00 -74.00 -120.00 -209.00
Operating Expenses
-78.00 -135.00 -213.00 -325.00 -469.00 -563.00 -611.00
Depreciation and Amortization
- - - - -7.00 -19.00 -28.00 -33.00 -43.00
Interest Expenses
- - -2.00 -3.00 -1.00 - - - - - -
Other Expenses
- - -93.00 -1.00 -449.00 - - -5.00 -46.00
WA Shares Outstanding
11.00 13.00 39.00 101.00 110.00 113.00 117.00
End of TXG's Analysis
CIK: 1770787 CUSIP: 88025U109 ISIN: US88025U1097 LEI: - UEI: -
Secondary Listings
TXG has no secondary listings inside our databases.